ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Bone marrow transplantation"

  • 2019 American Transplant Congress

    Expansion of Regulatory T and B Cells in Swine Rendered Tolerant of Allogeneic Vascularized Composite Allografts via Mixed Chimerism

    G. Saviane1, A. Lellouch1, A. Andrews1, L. Lantieri2, M. Randolph1, G. Benichou1, C. Cetrulo Jr1

    1Center for Transplantation Sciences, Division of Plastic Surgery, Boston, MA, USA, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 2European Georges Pompidou Hospital, University of Paris, Department of Plastic Surgery, Paris, France

    *Purpose: Prevention of acute rejection of vascularized composite allografts (VCAs) requires ongoing systemic immunosuppression, which subject patients to infectious, metabolic, reno-vascular and neoplastic complications. It…
  • 2019 American Transplant Congress

    Ten Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

    J. Leventhal1, J. Galvin1, L. Gallon1, D. Stare1, K. Ravindra2, M. Horwitz2, M. Abecassis1, S. Ildstad3

    1Northwestern U, Chicago, IL, 2Duke U, Durham, NC, 3U Louisville, Louisville, KY

    *Purpose: 37 subjects have been transplanted in a phase 2 protocol to induce tolerance in recipients of living donor renal allografts (KTx) based upon tolerogenic…
  • 2019 American Transplant Congress

    After 10 Years: The Results of HLA Mismatched Combined Kidney and Bone Marrow Transplantation for Renal Allograft Tolerance

    T. Kawai1, D. H. Sachs1, T. Spitzer1, N. Tolkoff-Rubin1, R. B. Colvin1, N. Elias1, M. Sykes2, A. Cosimi1

    1Massachusetts General Hospital, Boston, MA, 2Columbia University, NYC, NY

    *Purpose: Based on decades-long basic studies in animal models, we have applied combined kidney and donor bone marrow transplantation (CKBMT) for induction of allograft tolerance…
  • 2019 American Transplant Congress

    Conceptual Extension of SNP Based Abundance Profiling to Infer Donor Derived Cell-Free DNA Fraction as an Indication of Organ Rejection

    R. Sinha, K. Mickey, J. Grantham, M. Wissel, M. Altrich, S. Kleiboeker

    R&D, Viracor-Eurofins, Lee's Summit, MO

    *Purpose: Rejection is a major post-transplant complication for organ transplant recipients. Biopsy remains the standard to diagnose rejection, but other non-invasive methods, such as transcript…
  • 2018 American Transplant Congress

    Immunity and Tolerance after Bilateral Orthotopic Lung Transplant (BOLT) in Tandem with a CD3+/CD19+ Depleted Vertebral Bone Marrow Transplant (BOLT+BMT) from 1 of 8 HLA-Matched Cadaveric Donors

    P. Szabolcs,1 X. Chen,1 A. Donnenberg,2 M. Hill,1 J. Rowan,1 S. Mcintyre,1 G. Kurland,1 J. Barnum,1 J. McDyer.1

    1BMT-CT, Children Hospital of Pittsburgh UPMC, Pittsburgh, PA; 2IDM-HCC, University of Pittsburgh, Pittsburgh, PA.

    Primary immunodeficiency patients may develop pulmonary complications and most are ineligible for either lung transplant or BMT due to futility. We report our first 2…
  • 2018 American Transplant Congress

    Changes in Phenotype, Immune Suppressive, Function, and Gene Expression of Myeloid Derived Suppressor Cells in Patients Given Combined Kidney and Hematopoietic Cell Transplants in a Tolerance Protocol

    K. Jensen,1 P. Zheng,2 J. Xuhuai,2 A. Saraswathula,1 J. Scandling,3 S. Busque,4 J. Shizuru,5 R. Lowsky,5 A. Shori,4 H. Maecker,2 E. Engleman,1 E. Meyer,5 S. Strober.1

    1Immunology, Stanford School of Medicine, Stanford, CA; 2Human Immune Monitoring Center, Stanford School of Medicine, Stanford, CA; 3Nephrology, Stanford School of Medicine, Stanford, CA; 4Surgery, Stanford School of Medicine, Stanford, CA; 5Blood & Marrow Transplantation, Stanford School of Medicine, Stanford, CA.

    Tolerance induction after combined organ and hematopoietic cell transplantation can be achieved using conditioning with total lymphoid irradiation (TLI) and anti-thymocyte globulin (ATG), in both…
  • 2018 American Transplant Congress

    Recipient Conditioning Results in IL-33 Support of Potent Th1 Alloimmune Responses after CD4+ T Cells Upregulate ST2 during Lymphopenia Induced Proliferation

    G. Dwyer,1 L. Mathews,1 A. Lucas,1 B. Blazar,2 H. Turnquist.1

    1Starzl Transplantation Institute and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Department of Pediatrics, University of Minnesota, Minneapolis, MN.

    Purpose: IL-33 is typically associated with support of Th2 and Treg responses. Yet, recipient conditioning before allogeneic hematopoietic cell transplantation (alloHCT) releases IL-33 to promote…
  • 2018 American Transplant Congress

    Long-Term Nonhuman Primate Renal Allograft Survival without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation

    K. Hotta, T. Oura, A. Dehnadi, M. Matsunami, I. Rosales, R. Smith, R. Colvin, A. Cosimi, T. Kawai.

    Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA.

    Background: We have previously reported induction of renal allograft tolerance in nonhuman primates following an initial post-transplant period of conventional immunosuppression (IS) using a nonmyeloablative…
  • 2018 American Transplant Congress

    A Novel Conditioning Approach to Establish Chimerism Using Manipulation of JAK-STAT Pathways

    H. Xu, A. Merchak, L. Kahn, A. Chhabra, Y. Wen, Y. Huang, S. Ildstad.

    Institute for Cellular Therapeutics, University of Louisville, Louisville, KY.

    Hematopoietic chimerism establishes donor-specific tolerance to solid organ allografts. Targeting recipient immune cells (T, NK cells and macrophages) can effectively reduce the dose of total…
  • 2018 American Transplant Congress

    Characterization of Renal Allograft Tolerance Induction via Transient Mixed Chimerism in Non-Human Primates

    H. Sasaki,1 C. Thaiss,1 T. Oura,1 A. Rosales,2 R. Smith,2 R. Colvin,2 B. Cosimi,1 T. Kawai.1

    1Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston; 2Pathology, Massachusetts General Hospital, Boston.

    Background: We have previously reported long-term renal allograft tolerance after induction of transient mixed chimerism in non-human primates. However, some recipients developed late onset chronic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences